Hem › Njurcancer (renalcelskarcinom) › Georgia › Atlanta
Kliniska studier för Njurcancer (renalcelskarcinom) i Atlanta, GA
10 studier för Njurcancer (renalcelskarcinom) söker deltagare vid platser i och runt Atlanta (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RekryterarFas 1
- Research Site, Atlanta
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- Winship Cancer Institute of Emory University, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Atlanta VA Medical Center, Decatur · 6 mi bort
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekryterarFas 2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
RekryterarFas 2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RekryterarFas 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- och 1 fler
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RekryterarFas 1
- Emory University - Winship Cancer Institute, Atlanta
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RekryterarFas 1
- Xencor Investigative Site, Atlanta
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekryterarFas 1/2
- Winship Cancer Institute - Emory University, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
RekryterarFas 1/2
- Emory - Winship Cancer Institute, Atlanta
Njurcancer (renalcelskarcinom)-studier i andra städer
- Houston, TX35 studier
- New York City, NY27 studier
- Dallas, TX23 studier
- Nashville, TN23 studier
- St. Louis, MO23 studier
- Los Angeles, CA20 studier
- Boston, MA16 studier
- Baldwin Park, CA16 studier
- Pittsburgh, PA15 studier
- Philadelphia, PA15 studier
- Queens, NY15 studier
- Cleveland, OH14 studier
Andra studier i Atlanta
- Cancer (alla typer)49 studier
- Icke-småcellig lungcancer47 studier
- Multipelt myelom42 studier
- Bröstcancer41 studier
- Prostatacancer33 studier
- Akut myeloid leukemi31 studier
- Äggstockscancer29 studier
- Kolorektal cancer29 studier
- Lungcancer29 studier
- Metastaserande cancer28 studier
- Major depression25 studier
- Hjärtsvikt25 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.